Unanswered questions in Friedreich ataxia

Journal of Child Neurology

Volumn 27, Issue 9, 2012, Pages 1223-1229

  Lynch, David R ^a,b   Deutsch, Eric C ^a,b   Wilson, Robert B ^a   Tennekoon, Gihan ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

antioxidant; ataxia; cerebellum; dorsal root ganglion; frataxin; Friedreich; mitochondrion

Indexed keywords

ADENOSINE TRIPHOSPHATE; FRATAXIN; HISTONE DEACETYLASE; REACTIVE OXYGEN METABOLITE;

CEREBELLUM; CIRCADIAN RHYTHM; CONFERENCE PAPER; DNA DAMAGE; DNA METHYLATION; DORSAL ROOT; FRIEDREICH ATAXIA; GENE PRODUCT; MISSENSE MUTATION; MITOCHONDRION; NERVE CELL; NUCLEAR MAGNETIC RESONANCE IMAGING; PHENOTYPE; POINT MUTATION; PRIORITY JOURNAL; RESPIRATORY CHAIN; RNA SPLICING; SENSORY NERVE; SPASTICITY; SPINAL GANGLION; SYMPTOMATOLOGY;

FRIEDREICH ATAXIA; HUMANS; IRON-BINDING PROTEINS; NEURONS; REACTIVE OXYGEN SPECIES;

EID: 84865627075     PISSN: 08830738     EISSN: 17088283     Source Type: Journal    
DOI: 10.1177/0883073812453498     Document Type: Conference Paper

References (70)

1. Campuzano V, Montermini L, Molto MD, et al. Friedreich's ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion. Science. 1996 ; 271: 1423-1427 (Pubitemid 26089479)
2. Grabczyk E, Usdin K. The GAA*TTC triplet repeat expanded in Friedreich's ataxia impedes transcription elongation by T7 RNA polymerase in a length and supercoil dependent manner. Nucleic Acids Res. 2000 ; 28: 2815-2822 (Pubitemid 30488540)
3. Rotig A, de Lonlay P, Chretien D, et al. Aconitase and mitochondrial iron-sulphur protein deficiency in Friedreich ataxia. Nat Genet. 1997 ; 17: 215-217
4. Babcock M, de Silva D, Oaks R, et al. Regulation of mitochondrial iron accumulation by Yfh1p, a putative homolog of frataxin. Science. 1997 ; 276: 1709-1712 (Pubitemid 27421980)
5. Sparaco M, Gaeta LM, Santorelli FM, et al. Friedreich's ataxia: oxidative stress and cytoskeletal abnormalities. J Neurol Sci. 2009 ; 287: 111-118
6. Paupe V, Dassa EP, Goncalves S, et al. Ataxia. PLoS One. 2009 ; 4 (1). e4253
7. Pandolfo M. Iron and Friedreich ataxia. J Neural Transm Suppl. 2006 ; 70: 143-146 (Pubitemid 44622191)
8. Wong A, Yang J, Cavadini P, et al. The Friedreich's ataxia mutation confers cellular sensitivity to oxidant stress which is rescued by chelators of iron and calcium and inhibitors of apoptosis. Hum Mol Genet. 1999 ; 8: 425-430 (Pubitemid 29097330)
9. Harding AE. Friedreich's ataxia: a clinical and genetic study of 90 families with an analysis of early diagnostic criteria and intrafamilial clustering of clinical features. Brain. 1981 ; 104: 589-620 (Pubitemid 12202197)
10. Ben Hamida M, Belal S, Sirugo G, et al. Friedreich's ataxia phenotype not linked to chromosome 9 and associated with selective autosomal recessive vitamin E deficiency in two inbred Tunisian families. Neurology. 1993 ; 43: 2179-2183 (Pubitemid 23346943)
11. McCabe DJ, Ryan F, Moore DP, et al. Typical Friedreich's ataxia without GAA expansions and GAA expansion without typical Friedreich's ataxia. J Neurol. 2000 ; 247: 346-355 (Pubitemid 30364613)
12. Boesch S, Sturm B, Hering S, et al. Friedreich's ataxia: clinical pilot trial with recombinant human erythropoietin. Ann Neurol. 2007 ; 62: 521-524 (Pubitemid 350308777)
13. Herman D, Jenssen K, Burnett R, et al. Histone deacetylase inhibitors reverse gene silencing in Friedreich's ataxia. Nat Chem Biol. 2006 ; 2: 551-558 (Pubitemid 44413238)
14. Acquaviva F, Castaldo I, Filla A, et al. Recombinant human erythropoietin increases frataxin protein expression without increasing mRNA expression. Cerebellum. 2008 ; 7: 360-365
15. Willis JH, Isaya G, Gakh O, et al. Lateral-flow immunoassay for the frataxin protein in Friedreich's ataxia patients and carriers. Mol Genet Metab. 2008 ; 94: 491-497
16. Deutsch EC, Santani AB, Perlman SL, et al. A rapid, noninvasive immunoassay for frataxin: utility in assessment of Friedreich ataxia. Mol Genet Metab. 2010 ; 101: 238-245
17. Saccà F, Puorro G, Antenora A, et al. A combined nucleic acid and protein analysis in Friedreich ataxia: implications for diagnosis, pathogenesis and clinical trial design. PLoS One. 2011 ; 6: 1-9
18. Nachbauer W, Wanschitz J, Steinkellner H, et al. Correlation of frataxin content in blood and skeletal muscle endorses frataxin as a biomarker in Friedreich ataxia. Mov Disord. 2011 ; 26: 1935-1938
19. Raghavan SS, Gajewski A, Kolodny EH. Leukocyte sulfatidase for the reliable diagnosis of metachromatic leukodystrophy. J Neurochem. 1981 ; 36: 724-731 (Pubitemid 11178524)
20. Yutaka T, Kato T, Midorikawa M, et al. Diagnosis of Tay-Sachs disease by estimation of beta-N-acetylhexosaminidase activity using a radiolabeled hyaluronic acid-derived trisaccharide substrate. Clin Chim Acta. 1984 ; 137: 159-168 (Pubitemid 14194145)
21. De Biase I, Rasmussen A, Monticelli A, et al. Somatic instability of the expanded GAA triplet-repeat sequence in Friedreich ataxia progresses throughout life. Genomics. 2007 ; 90: 1-5 (Pubitemid 46891744)
22. De Biase I, Rasmussen A, Endres D, et al. Progressive GAA expansions in dorsal root ganglia of Friedreich's ataxia patients. Ann Neurol. 2007 ; 61: 55-60 (Pubitemid 46214244)
23. Hart LM, Ruige JB, Dekker JM, et al. Altered beta-cell characteristics in impaired glucose tolerant carriers of a GAA trinucleotide repeat polymorphism in the frataxin gene. Diabetes. 1999 ; 48: 924-926 (Pubitemid 29153098)
24. Dalgaard LT, Hansen T, Urhammer SA, et al. Intermediate expansions of a GAA repeat in the frataxin gene are not associated with type 2 diabetes or altered glucose-induced beta-cell function in Danish Caucasians. Diabetes. 1999 ; 48: 914-917 (Pubitemid 29153095)
25. Evans-Galea MV, Carrodus N, Rowley SM, et al. FXN methylation predicts expression and clinical outcome in Friedreich ataxia. Ann Neurol. 2012 ; 71: 487-497
26. De Castro M, Garcia-Planells J, Monros E, et al. Genotype and phenotype analysis of Friedreich's ataxia compound heterozygous patients. Hum Genet. 2000 ; 106: 86-92 (Pubitemid 30156399)
27. Cossee M, Durr A, Schmitt M, et al. Friedreich's ataxia: point mutations and clinical presentation of compound heterozygotes. Ann Neurol. 1999 ; 45: 200-206 (Pubitemid 29072366)
28. Forrest SM, Knight M, Delatycki MB, et al. The correlation of clinical phenotype in Friedreich ataxia with the site of point mutations in the FRDA gene. Neurogenetics. 1998 ; 1: 253-257 (Pubitemid 128685081)
29. McCormack ML, Guttmann RP, Schumann M, et al. Novel frataxin point mutations in two patients with Friedreich ataxia and unusual clinical features. J Neurol Neurosurg Psychiatry. 2000 ; 68: 661-664 (Pubitemid 30248838)
30. Delatycki MB, Knight M, Koenig M, et al. G130 V, a common FRDA point mutation, appears to have arisen from a common founder. Hum Genet. 1999 ; 105: 343-346 (Pubitemid 29476286)
31. Lynch DR, Lech G, Farmer JM, et al. Ataxia. Muscle Nerve. 2002 ; 25: 664-673
32. Lodi R, Rajagopalan B, Blamire AM, et al. Cardiac energetics are abnormal in Friedreich ataxia patients in the absence of cardiac dysfunction and hypertrophy: an in vivo 31P magnetic resonance spectroscopy study. Cardiovasc Res. 2001 ; 52: 111-119 (Pubitemid 32835244)
33. Lodi R, Hart PE, Rajagopalan B, et al. Antioxidant treatment improves in vivo cardiac and skeletal muscle bioenergetics in patients with Friedreich's ataxia. Ann Neurol. 2001 ; 49: 590-596 (Pubitemid 32429786)
34. Boesch S, Sturm B, Hering S, et al. Neurological effects of recombinant human erythropoietin in Friedreich's ataxia: a clinical pilot trial. Mov Disord. 2008 ; 23: 1940-1944
35. Di Prospero NA, Baker A, Jeffries N, Fischbeck KH. Neurological effects of high-dose idebenone in patients with Friedreich's ataxia: a randomised, placebo-controlled trial. Lancet Neurol. 2007 ; 6: 878-886 (Pubitemid 47404985)
36. Schulz JB, Dehmer T, Schöls L, et al. Oxidative stress in patients with Friedreich ataxia. Neurology. 2000 ; 55: 1719-1721
37. Myers LM, Lynch DR, Farmer JM, et al. Urinary isoprostanes in Friedreich ataxia: lack of correlation with disease features. Mov Disord. 2008 ; 23: 1920-1922
38. Emond M, Lepage G, Vanasse M, Pandolfo M. Increased levels of plasma malondialdehyde in Friedreich ataxia. Neurology. 2000 ; 55: 1752-1753
39. Haugen AC, Di Prospero NA, Parker JS, et al. Altered gene expression and DNA damage in peripheral blood cells from Friedreich's ataxia patients: cellular model of pathology. PLoS Genet. 2010 ; 6: e1000812
40. Jiralerspong S, Liu Y, Montermini L, et al. Frataxin shows developmentally regulated tissue-specific expression in the mouse embryo. Neurobiol Dis. 1997 ; 4: 103-113 (Pubitemid 27426390)
41. França MC, D'Abreu A, Yasuda CL, et al. A combined voxel-based morphometry and 1H-MRS study in patients with Friedreich's ataxia. J Neurol. 2009 ; 256: 1114-1120
42. Della Nave R, Ginestroni A, Diciotti S, et al. Axial diffusivity is increased in the degenerating superior cerebellar peduncles of Friedreich's ataxia. Neuroradiology. 2011 ; 53: 367-372
43. Akhlaghi H, Corben L, Georgiou-Karistianis N, et al. Superior cerebellar peduncle atrophy in Friedreich's ataxia correlates with disease symptoms. Cerebellum. 2011 ; 10: 81-87
44. Corben LA, Delatycki MB, Bradshaw JL, et al. Impairment in motor reprogramming in Friedreich ataxia reflecting possible cerebellar dysfunction. J Neurol. 2010 ; 257: 782-791
45. Koeppen AH, Davis AN, Morral JA. The cerebellar component of Friedreich's ataxia. Acta Neuropathol. 2011 ; 122: 323-330
46. Puccio H, Simon D, Cossee M, et al. Mouse models for Friedreich ataxia exhibit cardiomyopathy, sensory nerve defect and Fe-S enzyme deficiency followed by intramitochondrial iron deposits. Nat Genet. 2001 ; 27: 181-186 (Pubitemid 32157445)
47. Al-Mahdawi S, Pinto RM, Varshney D, et al. GAA repeat expansion mutation mouse models of Friedreich ataxia exhibit oxidative stress leading to progressive neuronal and cardiac pathology. Genomics. 2006 ; 88: 580-590 (Pubitemid 44540244)
48. Bhidayasiri R, Perlman S, Pulst SM, Geschwind DH. Late-onset Friedreich ataxia: phenotypic analysis, magnetic resonance imaging findings, and review of the literature. Arch Neurol. 2005 ; 62: 1865-1869 (Pubitemid 41785080)
49. Montermini L, Richter A, Morgan K, et al. Phenotypic variability in Friedreich ataxia: role of the associated GAA triplet repeat expansion. Ann Neurol. 1997 ; 41: 675-682 (Pubitemid 27212663)
50. Simon D, Seznec H, Gansmuller A, et al. Friedreich ataxia mouse models with progressive cerebellar and sensory ataxia reveal autophagic neurodegeneration in dorsal root ganglia. J Neurosci. 2004 ; 24: 1987-1995 (Pubitemid 38292812)
51. Fortuna F, Barboni P, Liguori R, et al. Visual system involvement in patients with Friedreich's ataxia. Brain. 2009 ; 132 (pt 1). 116-123
52. Lynch DR, Farmer JM, Rochestie D, Balcer LJ. Contrast letter acuity as a measure of visual dysfunction in patients with Friedreich ataxia. J Neuroophthalmol. 2002 ; 22: 270-274 (Pubitemid 35416837)
53. DiMauroSHiranoM.Mitochondrial DNA deletion syndromes. In: PagonRABirdTDDolanCRStephensK, eds. Gene Reviews [http://www.ncbi.nlm.nih.gov/ books/NBK1203/]. University of Washington, Seattle. Published December 17, 2003. Updated May 03, 2011.
54. Kompare M, Rizzo WB. Mitochondrial fatty-acid oxidation disorders. Semin Pediatr Neurol. 2008 ; 15: 140-149
55. Meyron-Holtz EG, Ghosh MC, Iwai K, et al. Genetic ablations of iron regulatory proteins 1 and 2 reveal why iron regulatory protein 2 dominates iron homeostasis. EMBO J. 2004 ; 23: 386-395 (Pubitemid 38294503)
56. Cooperman SS, Meyron-Holtz EG, Olivierre-Wilson H, et al. Microcytic anemia, erythropoietic protoporphyria, and neurodegeneration in mice with targeted deletion of iron-regulatory protein 2. Blood. 2005 ; 106: 1084-1091 (Pubitemid 41076458)
57. Grabill C, Silva AC, Smith SS, et al. MRI detection of ferritin iron overload and associated neuronal pathology in iron regulatory protein-2 knockout mice. Brain Res. 2003 ; 971: 95-106 (Pubitemid 36412068)
58. Santoro L, De Michele G, Perretti A, et al. Relation between trinucleotide GAA repeat length and sensory neuropathy in Friedreich's ataxia. J Neurol Neurosurg Psychiatry. 1999 ; 66: 93-96 (Pubitemid 29101498)
59. Koeppen AH. Friedreich's ataxia: pathology, pathogenesis, and molecular genetics. J Neurol Sci. 2011 ; 303: 1-12
60. Quercia N, Somers GR, Halliday W, et al. Friedreich ataxia presenting as sudden cardiac death in childhood: clinical, genetic and pathological correlation, with implications for genetic testing and counselling. Neuromuscul Disord. 2010 ; 20: 340-342
61. Smith DE. The effect of deafferentation on the postnatal development of Clarke's nucleus in the kitten-a Golgi study. Brain Res. 1974 ; 74: 119-130
62. Muñoz-Martínez EJ. Effects of activity in single sensory fibres on the discharge patterns of dorsal spinocerebellar tract cells. J Physiol. 1975 ; 245: 1-12
63. Murray M, Goldberger ME. Replacement of synaptic terminals in lamina II and Clarke's nucleus after unilateral lumbosacral dorsal rhizotomy in adult cats. J Neurosci. 1986 ; 6: 3205-3217 (Pubitemid 17186046)
64. Zouari M, Feki M, Ben Hamida C, et al. Electrophysiology and nerve biopsy: comparative study in Friedreich's ataxia and Friedreich's ataxia phenotype with vitamin E deficiency. Neuromuscul Disord. 1998 ; 8: 416-425 (Pubitemid 28388943)
65. Terenghi G. Peripheral nerve regeneration and neurotrophic factors. J Anat. 1999 ; 194 (pt 1). 1-14 (Pubitemid 29126690)
66. Chen HH, Frank E. Development and specification of muscle sensory neurons. Curr Opin Neurobiol. 1999 ; 9: 405-409 (Pubitemid 29389446)
67. Barbacid M. The Trk family of neurotrophin receptors. J Neurobiol. 1994 ; 25: 1386-1403 (Pubitemid 24325064)
68. Klein R. Role of neurotrophins in mouse neuronal development. FASEB J. 1994 ; 8 (10). 738-744 (Pubitemid 24229768)
69. Cossée M, Puccio H, Gansmuller A, et al. Inactivation of the Friedreich ataxia mouse gene leads to early embryonic lethality without iron accumulation. Hum Mol Genet. 2000 ; 9: 1219-1226 (Pubitemid 30248608)
70. Sharma R, De Biase I, Gómez M, et al. Friedreich ataxia in carriers of unstable borderline GAA triplet-repeat alleles. Ann Neurol. 2004 ; 56: 898-901 (Pubitemid 39578458)